Goldman Sachs Group Inc Corcept Therapeutics Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 473,021 shares of CORT stock, worth $26.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
473,021
Previous 478,574 1.16%
Holding current value
$26.2 Million
Previous $15.5 Million 40.73%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$29.51 - $46.26 $163,869 - $256,881
-5,553 Reduced 1.16%
473,021 $21.9 Million
Q2 2024

Aug 13, 2024
BUY
$22.21 - $34.48 $973,952 - $1.51 Million
43,852 Added 10.09%
478,574 $15.5 Million
Q1 2024

May 15, 2024
SELL
$21.1 - $27.46 $2.07 Million - $2.69 Million
-98,038 Reduced 18.4%
434,722 $11 Million
Q4 2023

Feb 13, 2024
BUY
$24.82 - $32.88 $3.08 Million - $4.08 Million
124,185 Added 30.39%
532,760 $17.3 Million
Q3 2023

May 14, 2024
SELL
$21.97 - $33.8 $2.73 Million - $4.2 Million
-124,185 Reduced 23.31%
408,575 $11.1 Million
Q3 2023

Nov 14, 2023
BUY
$21.97 - $33.8 $995,416 - $1.53 Million
45,308 Added 12.47%
408,575 $11.1 Million
Q2 2023

May 14, 2024
SELL
$21.44 - $25.15 $861,116 - $1.01 Million
-40,164 Reduced 9.96%
363,267 $8.08 Million
Q2 2023

Aug 14, 2023
SELL
$21.44 - $25.15 $861,116 - $1.01 Million
-40,164 Reduced 9.96%
363,267 $8.08 Million
Q1 2023

May 14, 2024
SELL
$19.2 - $24.47 $1.36 Million - $1.73 Million
-70,770 Reduced 14.92%
403,431 $8.74 Million
Q1 2023

May 11, 2023
SELL
$19.2 - $24.47 $1.36 Million - $1.73 Million
-70,770 Reduced 14.92%
403,431 $8.74 Million
Q4 2022

May 14, 2024
BUY
$19.95 - $29.96 $1.04 Million - $1.56 Million
52,208 Added 12.37%
474,201 $9.63 Million
Q4 2022

Feb 13, 2023
BUY
$19.95 - $29.96 $1.04 Million - $1.56 Million
52,208 Added 12.37%
474,201 $9.63 Million
Q3 2022

May 14, 2024
BUY
$24.7 - $29.12 $2.8 Million - $3.3 Million
113,353 Added 36.73%
421,993 $10.8 Million
Q3 2022

Nov 10, 2022
BUY
$24.7 - $29.12 $2.8 Million - $3.3 Million
113,353 Added 36.73%
421,993 $10.8 Million
Q2 2022

May 14, 2024
SELL
$17.33 - $25.3 $3.88 Million - $5.67 Million
-224,120 Reduced 42.07%
308,640 $7.34 Million
Q2 2022

Aug 15, 2022
SELL
$17.33 - $25.3 $692,264 - $1.01 Million
-39,946 Reduced 11.46%
308,640 $7.34 Million
Q1 2022

May 16, 2022
SELL
$16.53 - $25.21 $45,622 - $69,579
-2,760 Reduced 0.79%
348,586 $7.85 Million
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $3.55 Million - $4.85 Million
-207,637 Reduced 37.15%
351,346 $6.96 Million
Q3 2021

Nov 10, 2021
BUY
$19.68 - $22.53 $11 Million - $12.6 Million
558,983 New
558,983 $11 Million

Others Institutions Holding CORT

# of Institutions
350
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.92B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email